Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial

Nature Medicine 2026 Open access

Read full text
Authors: Jennifer M. Kwon, Francina Munell, Laure Le Goff, Kotaro Yuge, Tamaki Kato, Claude Cances, L. De Waele, Ian R. Woodcock, Eugenio M. Mercuri, C. Proud, B. Darras, Leslie H. Hayes
+6 more Maryam Saket Oskoui, Jeannie Visootsak, Gemma Williams, Andreja Ilić, Lina Yang, W. Ludo van der Pol
DOI: 10.1038/s41591-026-04233-9
Cited by: 2

Abstract

In the version of the article initially published, in the second paragraph of the “Safety” section, the text “one on the day of gastronomy surgery” has been amended to “one on the day of percutaneous endoscopic gastrostomy” in the HTML and PDF versions of the article.

Fields of Study & Subjects

Neurogenetic and Muscular Disorders Research Hereditary Neurological Disorders Nerve Injury and Rehabilitation

Publication details

Journal / source
Nature Medicine
Publisher
Springer Science and Business Media LLC
Volume
32
Issue
2
Pages
763–763
Publication date
28 January 2026
Language
EN